Total | Men | Women | ||||
---|---|---|---|---|---|---|
HR (95 % CI) | p | HR (95 % CI) | p | HR (95 % CI) | p | |
CHD mortality | 146/2158 | 86/1015 | 60/1143 | |||
Body mass index, 5 kg/m2 | 1.12 (1.10–1.14) | <0.001 | 1.11 (1.09–1.13) | 0.001 | 1.14 (1.11–1.17) | <0,001 |
Adj. Systolic BP | 1.14 (0.95–1.37) | 0.16 | 0.96 (0.72–1.28) | 0.81 | 1.31 (1.03–1.66) | 0,025 |
Adj. total cholesterol | 1.23 (1.05–1.45) | 0.010 | 1.05 (0.81–1.37) | 0.70 | 1.14 (1.11–1.17) | <0,001 |
Adj. fasting glucose | 1.22 (1.03–1.44) | 0.021 | 1.04 (0.80–1.36) | 0.76 | 1.38 (1.12–1.72) | 0,003 |
Adj. SBP & T Chol. | 1.11 (0.93–1.34) | 0.25 | 0.94 (0.71–1.26) | 0.70 | 1.27 (0.99–1.62) | 0,051 |
Adj. SBP & FPG | 1.12 (0.93–1.35) | 0.21 | 0.93 (0.70–1.24) | 0.63 | 1.30 (1.03–1.64) | 0,025 |
Adj. T Chol & FPG | 1.19 (1.00–1.41) | 0.050 | 1.11 (0.78–1.33) | 0.90 | 1.34 (1.07–1.67) | 0,008 |
Adjusted for all 3 factors | 1.10 (0.91–1.32) | 0.31 | 0.91 (0.68–1.22) | 0.55 | 1.26 (1.00–1.60) | 0,050 |
Incident diabetes | 284/2136 | 146/1014 | 138/1122 | |||
Body mass index, 5 kg/m2 | 1.73 (1.54–1.93) | <0.001 | 2.11 (1.75–2.54) | 0.001 | 1.56 (1.35–1.79) | <0,001 |
Adj. Systolic BP | 1.71 (1.52–1.93) | <0.001 | 2.13 (1.73–2.63) | 0.001 | 1.54 (1.32–1.79) | <0,001 |
Adj. total cholesterol | 1.71 (1.53–1.91) | 0.001 | 2.06 (1.70–2.49) | 0.001 | 1.56 (1.35–1.79 | 0,001 |
Adj. fasting glucose | 1.71 (1.52–1.91) | 0.001 | 2.10 (1.73–2.55) | 0.001 | 1.55 (1.34–1.78 | 0,001 |
Adj. SBP & T Chol. | 1.70 (1.50–1.92) | 0.001 | 2.09 (1.69–2.58) | 0.001 | 1.53 (1.32–1.79) | 0,001 |
Adj. SBP & FPG | 1.68 (1.49–1.90) | <0.001 | 2.09 (1.69–2.58) | 0.001 | 1.52 (1.31–1.77) | <0,001 |
Adj. T Chol & FPG | 1.69 (1.51–1.90) | 0.001 | 2.03 (1.67–2.48) | 0.001 | 1.55 (1.34–1.78) | 0,001 |
Adjusted for all 3 factorsa | 1.67 (1.48–1.89) | <0.001 | 2.05 (1.65–2.54) | 0.001 | 1.52 (1.31–1.77) | <0,001 |